Sona Dimidjian1, Sherryl H Goodman2, Jennifer N Felder1, Robert Gallop3, Amanda P Brown2, Arne Beck4. 1. Department of Psychology and Neuroscience, University of Colorado Boulder. 2. Department of Psychology, Emory University. 3. Department of Mathematics, Applied Statistics Program, West Chester University. 4. Kaiser Permanente Colorado-Institute for Health Research.
Abstract
OBJECTIVE: Clinical decision-making regarding the prevention of depression is complex for pregnant women with histories of depression and their health care providers. Pregnant women with histories of depression report preference for nonpharmacological care, but few evidence-based options exist. Mindfulness-based cognitive therapy has strong evidence in the prevention of depressive relapse/recurrence among general populations and indications of promise as adapted for perinatal depression (MBCT-PD). With a pilot randomized clinical trial, our aim was to evaluate treatment acceptability and efficacy of MBCT-PD relative to treatment as usual (TAU). METHOD:Pregnant adult women with depression histories were recruited from obstetric clinics at 2 sites and randomized to MBCT-PD (N = 43) or TAU (N = 43). Treatment acceptability was measured by assessing completion of sessions, at-home practice, and satisfaction. Clinical outcomes were interview-based depression relapse/recurrence status and self-reported depressive symptoms through 6 months postpartum. RESULTS: Consistent with predictions, MBCT-PD for at-risk pregnant women was acceptable based on rates of completion of sessions and at-home practice assignments, and satisfaction with services was significantly higher for MBCT-PD than TAU. Moreover, at-risk women randomly assigned to MBCT-PD reported significantly improved depressive outcomes compared with participants receiving TAU, including significantly lower rates of depressive relapse/recurrence and lower depressive symptom severity during the course of the study. CONCLUSIONS:MBCT-PD is an acceptable and clinically beneficial program for pregnant women with histories of depression; teaching the skills and practices of mindfulness meditation and cognitive-behavioral therapy during pregnancy may help to reduce the risk of depression during an important transition in many women's lives. (c) 2016 APA, all rights reserved).
RCT Entities:
OBJECTIVE: Clinical decision-making regarding the prevention of depression is complex for pregnant women with histories of depression and their health care providers. Pregnant women with histories of depression report preference for nonpharmacological care, but few evidence-based options exist. Mindfulness-based cognitive therapy has strong evidence in the prevention of depressive relapse/recurrence among general populations and indications of promise as adapted for perinatal depression (MBCT-PD). With a pilot randomized clinical trial, our aim was to evaluate treatment acceptability and efficacy of MBCT-PD relative to treatment as usual (TAU). METHOD: Pregnant adult women with depression histories were recruited from obstetric clinics at 2 sites and randomized to MBCT-PD (N = 43) or TAU (N = 43). Treatment acceptability was measured by assessing completion of sessions, at-home practice, and satisfaction. Clinical outcomes were interview-based depression relapse/recurrence status and self-reported depressive symptoms through 6 months postpartum. RESULTS: Consistent with predictions, MBCT-PD for at-risk pregnant women was acceptable based on rates of completion of sessions and at-home practice assignments, and satisfaction with services was significantly higher for MBCT-PD than TAU. Moreover, at-risk women randomly assigned to MBCT-PD reported significantly improved depressive outcomes compared with participants receiving TAU, including significantly lower rates of depressive relapse/recurrence and lower depressive symptom severity during the course of the study. CONCLUSIONS:MBCT-PD is an acceptable and clinically beneficial program for pregnant women with histories of depression; teaching the skills and practices of mindfulness meditation and cognitive-behavioral therapy during pregnancy may help to reduce the risk of depression during an important transition in many women's lives. (c) 2016 APA, all rights reserved).
Authors: Anne Maj van der Velden; Willem Kuyken; Ulla Wattar; Catherine Crane; Karen Johanne Pallesen; Jesper Dahlgaard; Lone Overby Fjorback; Jacob Piet Journal: Clin Psychol Rev Date: 2015-02-11
Authors: Willem Kuyken; Ed Watkins; Emily Holden; Kat White; Rod S Taylor; Sarah Byford; Alison Evans; Sholto Radford; John D Teasdale; Tim Dalgleish Journal: Behav Res Ther Date: 2010-08-13
Authors: Lee S Cohen; Lori L Altshuler; Bernard L Harlow; Ruta Nonacs; D Jeffrey Newport; Adele C Viguera; Rita Suri; Vivien K Burt; Victoria Hendrick; Alison M Reminick; Ada Loughead; Allison F Vitonis; Zachary N Stowe Journal: JAMA Date: 2006-02-01 Impact factor: 56.272
Authors: Arianna Di Florio; Liz Forty; Katherine Gordon-Smith; Jess Heron; Lisa Jones; Nicholas Craddock; Ian Jones Journal: JAMA Psychiatry Date: 2013-02 Impact factor: 21.596
Authors: A Roca; M L Imaz; A Torres; A Plaza; S Subirà; M Valdés; R Martin-Santos; Ll Garcia-Esteve Journal: J Affect Disord Date: 2013-04-06 Impact factor: 4.839
Authors: Susan Kendig; John P Keats; M Camille Hoffman; Lisa B Kay; Emily S Miller; Tiffany A Moore Simas; Ariela Frieder; Barbara Hackley; Pec Indman; Christena Raines; Kisha Semenuk; Katherine L Wisner; Lauren A Lemieux Journal: Obstet Gynecol Date: 2017-03 Impact factor: 7.661